NCT04449133View on ClinicalTrials.gov

Study of AD128 Versus Placebo in Obstructive Sleep Apnea

PHASE2CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

July 3, 2020

Primary Completion Date

October 30, 2020

Study Completion Date

October 31, 2020

Conditions

Obstructive Sleep Apnea

Interventions

DRUG

AD128

Oral administration of two capsules before sleep for 7 days.

DRUG

Placebo

Oral administration of two capsules before sleep for 7 days.

Trial Locations (1)

Unknown

Istituto Auxologico Italiano,Ospedale San Luca, Milan

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

YGHEA, CRO Division of Ecol Studio spa

INDUSTRY

collaborator

STM Pharma PRO srl

UNKNOWN

collaborator

Apnimed Inc.

UNKNOWN

lead

Istituto Auxologico Italiano

OTHER